AI Briefing#genomics
The latest AI and developer news about #genomics, with the original source and a short summary.
The latest AI and developer news about #genomics, with the original source and a short summary.
AlphaGenome 2 increases single-cell eQTL reproducibility by approximately 2x and transitions to a condition-specific prediction architecture.
The partnership aims to replant forests with diverse, heat-tolerant specimens after populations dwindled to 5% of historic numbers.
The 14.8B model averages 66.7% on five DNA benchmarks, outperforming Qwen3-14B by 27 points and running on a single 80 GB GPU.
Google teams have published 90 peer-reviewed papers with over 90,000 citations and provided over $60 million in funding to health research organizations in 2026.
950 Claude agents processed 210 million tokens over 21 hours to identify the uncharacterized reverse transcriptase system ART.
Inocras achieved a 72% reduction in analysis costs and a 47% improvement in processing speed by adopting AWS HealthOmics, and disclosed the design principles of the event-driven automation and GitOps deployment system that made this possible.
Google DeepMind has released AlphaGenome Atlas, a 1-petabyte dataset predicting the impact of every single nucleotide variant in human DNA.
Google has released the AlphaGenome Atlas and AVI scores to predict the effects of 9 billion variants in the human genome.
Google has released AlphaGenome Atlas, a 1-petabyte database that pre-computes the impact of 9 billion variants in the human genome.
OpenAI has released GeneBench-Pro, which evaluates AI agents' ability to conduct biological research.
OpenAI has released case studies of Genebench-Pro, a benchmark that evaluates the ability to analyze biological data.
GeneBench-Pro, a new benchmark for testing AI performance in genetics, biology, and scientific research using complex real-world datasets, has been released.
Developed in collaboration with Microsoft, Talos increases rare disease diagnosis rates and reduces the workload of medical staff through automated genomic reanalysis.
OpenAI's reasoning model re-analyzed undiagnosed rare genetic disease cases and led to 18 new diagnoses.
A new DNA synthesis technology called 'Sidewinder' has been developed that quickly and accurately implements genetic sequences designed by generative AI.
Hugging Face released **Carbon-3B**, claiming Evo2-7B-level performance at **275x the speed**.
OpenAI unveiled GPT-Rosalind, a specialized AI tool for life sciences research, targeting early-stage drug discovery.